Introduction
Hypertriglyceridaemia has become recognized as the commonest manifestation of hyperliproproteinaemia. Recent reports on this subject have stressed that multiple contributing factors are often present which may be of primary and/or secondary nature (Brunzell, Chait and Bierman, 1978; Brunzell and Schrott, 1973) . Moreover, the existence of both primary and secondary factors is common, particularly in patients with severe degrees of hypertriglyceridaemia (Brunzell et al., 1978) . Although the distinction between very low density lipoproteins (VLDL) and chylomicrons remains clear from the standpoint of in vitro recognition, the intermittent co-existence of these particles in patients with severe hypertriglyceridaemia has led to some difficulty in sharp differentiation at the clinical level (Francois et al., 1977) . Causes for this include the fact that VLDL and chylomicrons share a common disposal mechanism and the fact that substantial heterogeneity exists within the macromolecular category defined as 'very low density lipoprotein' Strejo, Kallai and Steiner, 1977) . On the 9th hospital day nicotinic acid was added to the regimen, initially at a dose of 100 mg 4 times/day. Efforts were made to increase the dose within the limits of the patient's tolerance for the medication. Pruritus and skin discomfort did produce some difficulty, but ultimately the nicotinic acid was increased to 300 mg 4 times/day. The serial reduction in serum triglyceride that resulted is presented in Fig. 2 . The serum cholesterol concentration fell also, ultimately reaching a level of 9.4 mmol/l.
The patient was discharged home on the 17th hospital day and was instructed to continue to follow the 800-calorie diet with 35% carbohydrate restriction. His discharge medications were lente insulin 55 units/day and nicotinic acid 300 mg 4 times/day. The patient was observed during the subsequent month in the out-patient clinic and appeared to follow the instructions given to him at the time of discharge. His weight remained stable, his fasting glucose was in the 7.3-8-3 mmol/l range, and his serum triglyceride concentration continued to fall. At 30 days after the initial admission the patient had a serum triglyceride of 2-1 mmol/l with serum cholesterol of 9.4 mmol/l. His serum sodium had increased to 140 mmol/l (Fig. 3) .
Methods
Serum samples were collected in the postabsorptive state and processed in a routine fashion. Serum triglyceride measurements were made by an enzymatic method for the estimation of glycerol following lipase-induced triglyceride lipolysis (Rautela et al., 1974) . Most of the samples were diluted several-fold in order to produce final triglyceride concentrations of < 5-5 mmol/l. Measurement of serum total cholesterol was accomplished by an enzymatic method wherein cholesterol oxidase acting upon cholesterol led to liberation of hydrogen peroxide. The hydrogen peroxide in turn led to production of an oxidized product of a chromogenic substrate, measurable by spectrophotometry (Rautela and Liedtke, 1978) . A cholesterol esterase was used in the initial step in order to convert the total serum cholesterol to the free form. As in the case of the triglyceride assay, it was necessary to dilute the serum samples several-fold in order to produce a final concentration in the accurately measurable range. (based on mean triglyceride molecular weight of 875 daltons-factor = 0-0114).
The severity of this patient's hypertriglyceridaemie exceeds that of any reported instance found by the authors in the literature. The fasting concentration initially presented by this patient was more than twice the upper end of the range listed by Brunzell et al. (1978) in their recent discussion of marked hypertriglyceridaemia. In this case, as in others, severe hypertriglyceridaemia probably resulted from a combination of factors (Brunzell et al., 1975a; Brunzell and Schrott, 1973) . Based on the absence of obvious low density lipoprotein or intermediate density lipoprotein elevation in this patient and the presence of a history of hyperlipidaemia in his brother, it appears that the underlying diagnosis would be best described as familial hypertriglyceridaemia. This condition is characterized by increased endogenous VLDL production. The occasional elevation of chylomicrons in fasting serum samples of such patients is explained on the basis of saturation of the lipoprotein lipase removal mechanism secondary to excessively high levels of VLDL production and degradation . The findings in this patient indicated a VLDL problem, with failure of the plasma to clear after 16 hr of refrigeration and with a massive pre-3-lipoprotein peak on serum electrophoresis (Levy et al., 1972) . The absence of evidence of chylomicrons in this patient's fasting samples may be construed as an indication that lipoprotein lipase was at least minimally adequate.
In addition to the primary abnormality, this patient also had secondary hyperlipoproteinaemia related to his untreated diabetes mellitus. Untreated diabetes mellitus is known to predispose patients to the development of hypertriglyceridaemia through a variety of mechanisms. The state of insulin deficiency and/or glucagon excess is associated with increased tissue lipase activity, resulting in increased transport of free fatty acids from adipose tissue to the liver (McGarry, 1979) . Such fatty acids then become potential substrate for the production of VLDL. Additionally, severe insulin deficiency leads to reduction in adipose tissue lipoprotein lipase activity with the possibility that elevated serum levels of VLDL and/or chylomicrons will develop (Olefsky, Farquhar and Reaven, 1974) . Finally, it is not certain that all of the evidence for accelerated VLDL synthesis in diabetes mellitus is explained on the basis of increased fatty acid flux from adipose tissue, and it may be that generous intra-hepatic insulin concentrations play a role in patients with peripheral insulin resistance due to obesity or other diabetogenic factors (Nikkila, Huttunen and Ehnholm, 1977; Kyner et al., 1976) . Unfortunately, endogenous insulin concentrations were not assessed in this patient.
Strong consideration was given to the possibility that alcoholism had contributed to the development and maintenance of hypertriglyceridaemia in this patient, but repeated questioning on this point to the patient and several relatives clearly indicated that there had been no ethanol consumption for at least 2 weeks. Ethanol is felt to induce intrahepatic triglyceride synthesis on the basis of NAD reduction in conjunction with generous availability of acetate (Lieber, 1977) . These alterations are acute and transitory, leading to secondary hypertriglyceridaemia of only a few days' duration. On the other hand, there is evidence that alcoholic liver disease leads to abnormalities in lipoprotein structure and metabolism that can produce a more protracted hypertriglyceridaemia (Sabesin et al., 1977) . Although this patient probably did have a degree of alcoholic liver disease, based on the firm, enlarged liver and the spider angiomata, it is unlikely that this mechanism played a major role in his lipid disorder considering the absence of substantial abnormalities in liver function and the mildness of the hypertriglyceridaemia that has been reported in this association.
Insulin therapy administered in conjunction with the low-calorie carbohydrate-restricted diet was effective in initiating a substantial reduction in this patient's serum triglyceride concentration. Within one week a 50 % decrease had been achieved down to a level of 132 mmol/l. At this point, however, the patient still had severe fasting lipaemia and it was elected to add a second agent. Insulin is likely to have improved triglyceride clearance by enhancing lipoprotein lipase activity (Brunzell, Porte and Bierman, 1975b) , and it is also probable that insulin led to a reduction in the rate of VLDL production by reducing the supply of free fatty acids to the liver (McGarry, 1979; Olefsky et al., 1974) . Administration of nicotinic acid in modest quantities led to a sharp further reduction in the serum triglyceride concentration, suggesting that this substance was of particular value in the treatment of the patient's hypertriglyceridaemia. Nicotinic acid is known to produce a rapid reduction in the rate of hepatic VLDL production and it is probable that this effect is largely or entirely secondary to its potent anti-lipolytic action (Kudchodkar et al., 1978; Yeshuran and Gotto, 1976) . In a recent review of this subject, Levy stated that decreases in serum triglyceride level of over 60 % may result from use of nicotinic acid (Levy, 1977) . A maintenance dose in the range of 3 to 9 g/day has been recommended. In the present patient it is notable that the reduction in serum triglyceride concentration ultimately achieved on nicotinic acid therapy (combined with insulin and diet restriction) was in the range of 98%.
Moreover, the maximum dosage used was 1.2 g/day, or only 40% of the minimum maintenance dose level recommended by Levy. Thus, it appears that nicotinic acid is particularly effective in the treatment of severe hypertriglyceridaemia generated by the interaction of familial hypertriglyceridaemia and untreated diabetes mellitus. Since the use of nicotinic acid is frequently limited by side effects of flushing and pruritus, the identification of an effective derivative agent lacking these effects would be of great importance. Tetranicotinoylfructose may merit an investigative trial in this regard.
The data summarized in Fig. 3 
